This announcement is a separate document:
康希诺：北京市竞天公诚律师事务所关于康希诺生物股份公司调整2021年限制性股票激励计划授予价格相关事项的法律意见书
Kangxino: Legal opinion from Beijing Jingtian Gongcheng Law Firm on matters relating to the adjustment of the price granted to Kangxino Biotech Co., Ltd. in 2021 restricted stock incentive plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated